diabetes
GBS, Johns Hopkins Partner to Accelerate Development of Saliva-Based Dx Tests
The program will support Johns Hopkins' research into saliva testing and diagnostics and will help GBS form its commercialization strategy for two saliva-based tests.
WHO Updates Essential Diagnostics List, Urges Countries to Prioritize Investments in Testing
For the first time, WHO's essential diagnostics list includes tests that it recommends should also not be supplied because they are unreliable, among other reasons.
Trinity Biotech Q3 Revenues Rise 30 Percent
Though its point-of-care revenues fell, the firm's clinical laboratory sales for the third quarter rose 44 percent over the prior-year quarter
Proteomics International Inks Italian Distribution Deal for Diabetic Kidney Disease Immunoassay
The ELISA-based test, which has CE marking, uses protein signatures in blood to detect the onset of kidney disease in type 2 diabetics.
Patia Biopharma, Precision Diabetes to Collaborate on Diabetes Biomarker Development
The companies are currently working together to commercialize their respective products including genetic tests for type 2 diabetes and gestational diabetes risk.